sameAs
Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthoodEphA5 and ephrin-A2 expression during optic nerve regeneration: a 'two-edged sword'The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.Eph/ephrin expression in the adult rat visual system following localized retinal lesions: localized and transneuronal up-regulation in the retina and superior colliculus.Differential effects of 670 and 830 nm red near infrared irradiation therapy: a comparative study of optic nerve injury, retinal degeneration, traumatic brain and spinal cord injury.Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle.Early intensive hand rehabilitation after spinal cord injury ("Hands On"): a protocol for a randomised controlled trial.Early proliferation does not prevent the loss of oligodendrocyte progenitor cells during the chronic phase of secondary degeneration in a CNS white matter tract.Paranode Abnormalities and Oxidative Stress in Optic Nerve Vulnerable to Secondary Degeneration: Modulation by 670 nm Light TreatmentIron oxide-induced thermal effects on solid-state upconversion emissions in NaYF4:Yb,Er nanocrystals.rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector.Changes to mitochondrial ultrastructure in optic nerve vulnerable to secondary degeneration in vivo are limited by irradiation at 670 nmEarly exercise after spinal cord injury ('Switch-On'): study protocol for a randomised controlled trialThe influence of NaYF₄:Yb,Er size/phase on the multimodality of co-encapsulated magnetic photon-upconverting polymeric nanoparticles.Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury.An Unexpected Transient Breakdown of the Blood Brain Barrier Triggers Passage of Large Intravenously Administered Nanoparticles.FGF-2 is required to prevent astrogliosis in the facial nucleus after facial nerve injury and mechanical stimulation of denervated vibrissal muscles.Activity-dependent plasticity: implications for recovery after spinal cord injury.Intensive exercise program after spinal cord injury ("Full-On"): study protocol for a randomized controlled trial.Schwann cells overexpressing FGF-2 alone or combined with manual stimulation do not promote functional recovery after facial nerve injury.Chapter 23: Manual stimulation of target muscles has different impact on functional recovery after injury of pure motor or mixed nerves.Developing a spinal cord injury research strategy using a structured process of evidence review and stakeholder dialogue. Part III: outcomes.Developing a spinal cord injury research strategy using a structured process of evidence review and stakeholder dialogue. Part II: Background to a research strategy.Characterization of polymeric nanoparticles for treatment of partial injury to the central nervous system.Achieving assessor accuracy on the International Standards for Neurological Classification of Spinal Cord Injury.Regulation of Human PAX6 Expression by miR-7.Specific combinations of ion channel inhibitors reduce excessive Ca(2+) influx as a consequence of oxidative stress and increase neuronal and glial cell viability in vitro.Demonstrating efficacy in preclinical studies of cellular therapies for spinal cord injury - how much is enough?Short-term low intensity PMF does not improve functional or histological outcomes in a rat model of transient focal cerebral ischemia.Exogenous metallothionein-IIA promotes accelerated healing after a burn wound.Early Decompression following Cervical Spinal Cord Injury: Examining the Process of Care from Accident Scene to Surgery.Wiring up the visual system.Early Rapid Neurological Assessment for Acute Spinal Cord Injury Trials.Prolonged glutamate excitotoxicity increases GluR1 immunoreactivity but decreases mRNA of GluR1 and associated regulatory proteins in dissociated rat retinae in vitro.Culture conditions affect proliferative responsiveness of olfactory ensheathing glia to neuregulins.Near infrared light reduces oxidative stress and preserves function in CNS tissue vulnerable to secondary degeneration following partial transection of the optic nerve.Recovery of whisking function after manual stimulation of denervated vibrissal muscles requires brain-derived neurotrophic factor and its receptor tyrosine kinase B.Repeated ultrasound guided fetal injections of corticosteroid alter nervous system maturation in the ovine fetus.Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep.Reinnervation of the superior colliculus delays down-regulation of ephrin A2 in neonatal rat.
P50
Q28484561-5004D0DB-A9B1-4532-919F-C2313349ABB0Q28570871-4A87DAB2-F572-4D3A-8CD2-939DF13840CEQ30490602-884188A0-7FE1-4998-955C-50B6C8C0CCF6Q33226408-B1F1F6CF-DCCA-4DCF-92A0-A2251C4B6FE3Q34020693-FAB89B16-2DBA-4F74-9DAF-50FA29DD5341Q34098992-7AF03FB0-41BB-4148-BBA9-A32DFC7C73FEQ34547238-5385BC62-B307-4C87-9FB3-F4B8CCB25675Q34775898-EE908A93-52F6-4763-BCA8-2C19341799ACQ34805453-B7A49392-CB10-4627-8AE5-8CF8D58342B1Q34820831-B9346A6E-39D5-4742-B33E-51F579663F65Q34974863-735F1377-616A-4BD6-90E0-A1C7FA96F2BEQ34980445-40DB11C4-DFBF-4B8E-B8A0-772D53A2955FQ35060389-A656FC78-655F-43FD-9CF1-1C1CCEC34D7EQ35302854-0CD307CB-2504-4C60-A7BA-0FC1563FE95FQ35674443-DCCBE6F4-1B2E-43C5-BC60-51EFF3035017Q36651048-2D55D37A-5CD0-4DD9-B760-13292C6D8D4AQ36765411-ECBF5F25-1E4C-4AFF-8592-64FA04E3017AQ37207510-D7B08471-74BA-455A-8E39-AF19EF245496Q37359192-8A1B6D19-2B33-4837-809A-6308C2376274Q37383541-5B3961D4-5D16-48BE-A666-F14AFF2C5271Q37580207-7D76E03D-FDA0-4AA6-92EB-C35A3371A4B3Q38388999-67E07901-49EA-4D50-B8AF-062C44F19856Q38534358-586C2D11-0122-45C6-B75C-84EFD3E59566Q38631217-B95D1C2D-4464-4783-9714-99A676D7AE8BQ38717760-4BF81B9E-0DE7-4CAE-AF03-0DBE677F1FD9Q38969022-C18308A6-C545-473C-9BB5-C6D1D5D13590Q39304555-71A5D80D-0DB8-4CE7-B489-499A3B2012D8Q39409464-582695AD-6908-4005-A8D4-F021177AD416Q39621840-B5918602-C52F-4AD5-85A1-5F4C33DC2B4EQ39898021-56CB671F-1284-4779-AE32-D19C29C15CCDQ40229080-F78F1628-DF9A-4920-89E7-920494B538B7Q40430829-61AEC921-EEAC-4D8E-995D-C3DB9280B410Q40502510-4A4B0AC7-9CD6-4E34-97F2-B358875B047BQ41190004-D12E5381-B957-4FCF-A562-40005359B89DQ42509422-8CAA8DF1-AEE4-465E-89E8-FE22CD57D306Q42915076-BE1BA8FC-2F61-457F-B4B9-1C57388F2A8CQ42988078-4B991F85-A337-4FF5-84DE-DD7CE1C331FBQ43602089-59505E7D-6FC2-4860-B955-70E1A55AF93FQ43621447-94841ACA-6915-49B7-8733-D888FF449626Q43690136-F9B13559-915C-4933-A236-2666F1BE0783
P50
description
neuroplasticity and neuroscience researcher
@en
onderzoeker
@nl
հետազոտող
@hy
name
Sarah A Dunlop
@ast
Sarah A Dunlop
@nl
Sarah A. Dunlop
@en
Sarah A. Dunlop
@sq
Sarah Dunlop
@de
Sarah Dunlop
@es
Sarah Dunlop
@fr
Sarah Dunlop
@pt
type
label
Sarah A Dunlop
@ast
Sarah A Dunlop
@nl
Sarah A. Dunlop
@en
Sarah A. Dunlop
@sq
Sarah Dunlop
@de
Sarah Dunlop
@es
Sarah Dunlop
@fr
Sarah Dunlop
@pt
altLabel
Sarah A Dunlop
@en
Sarah Dunlop
@en
prefLabel
Sarah A Dunlop
@ast
Sarah A Dunlop
@nl
Sarah A. Dunlop
@en
Sarah A. Dunlop
@sq
Sarah Dunlop
@de
Sarah Dunlop
@es
Sarah Dunlop
@fr
Sarah Dunlop
@pt
P106
P1153
7006299923
P21
P31
P496
0000-0002-1306-3962